Clinical Trials
Study Title:
A Phase II Randomized Trial of Olaparib (NSC 747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer.
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, Harriet Eldredge-Hindy, at eldredge@musc.edu.
Study Coordinator, Zachary Bargeloh, at bargeloh@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |